ArticleApplied biochemistry and biotechnology2026
Bioactivities and Phytochemical Potential of Vatica Diospyroides Flower Extracts.
Article in Applied biochemistry and biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
This study investigated the phytochemical composition and bioactivities of Vatica diospyroides flower extracts to evaluate their potential for natural product and cosmetic applications. Phytochemical screening confirmed the presence of alkaloids, phenolics, flavonoids, and terpenoids, with ethanol extracts exhibiting the highest abundance of bioactive constituents. In all extracts, total phenolic content was higher than total flavonoid content. The ethanol bud extract showed strong antioxidant activity, with an IC₅₀ value of 0.00050 ± 0.00003 µg/mL in the DPPH assay. Anti-inflammatory activity was demonstrated by 70% inhibition of nitric oxide production in lipopolysaccharide-stimulated macrophages at 2.5 mg/mL. The extract also exhibited potent tyrosinase inhibition (90% at 2.5 mg/mL), comparable to kojic acid, indicating potential for skin-brightening applications. Antimicrobial testing against Cutibacterium acnes showed dose-dependent inhibitory activity. In a scratch wound-healing assay, the ethanol bud extract enhanced fibroblast migration, achieving 46.7% wound closure after 48 h, approaching the effect of vitamin C. Collectively, these results demonstrate that V. diospyroides flower extracts possess multifunctional bioactivities relevant to cosmetic and dermatological applications. Further studies on formulation stability, safety, and clinical efficacy are warranted to support their development as natural cosmetic ingredients.
Indexed as
Identifiers
41686353What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.